SCHEMBL30143555

SCHEMBL30143555

c1ccc2cc3c(Sc4cccc5cc6ccccc6cc45)cccc3cc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.44
KDM4E B2RXH2 3/20 0.44
GAA P10253 2/20 0.44
HSD17B10 Q99714 4/20 0.42
HIF1A Q16665 2/20 0.42
CYP1B1 Q16678 1/20 0.42
IFNAR1 P17181 1/20 0.42
MAPK1 P28482 3/20 0.41
LMNA P02545 2/20 0.41
NPY1R P25929 1/20 0.41
NPY2R P49146 1/20 0.41
MAPT P10636 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CYP1A2 P05177 3/20 0.39
HPGD P15428 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
ERBB2 P04626 1/20 0.39
FYN P06241 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2942873 1.00 ALDH1A1 (0.44) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL3062936 0.87 KDM4E (0.42) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL1395162 0.86 ALDH1A1 (0.44) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL8812334 0.84 ALDH1A1 (0.43) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL28618004 0.82 ALDH1A1 (0.41) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL21856641 0.82 ALDH1A1 (0.46) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL3698024 0.82 ALDH1A1 (0.41) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL15635517 0.82 ALDH1A1 (0.46) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL29226736 0.81 ALDH1A1 (0.41) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL40420 0.80 ALDH1A1 (0.38) ALDH1A1KDM4EGAAHSD17B10HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115505100-A Epoxy resin based on spirosilafluorene as skeleton and preparation method and application thereof 中国石油化工股份有限公司 2022-12-23 CN claimed
CN-115505099-A Epoxy resin containing carbazole structure and preparation method and application thereof 中国石油化工股份有限公司 2022-12-23 CN claimed
EP-3848399-B1 TRANSITION METAL COMPOUND AND METHOD FOR PRODUCING OLEFIN POLYMER IDEMITSU KOSAN CO (JP) 2024-07-10 EP disclosed
CN-115505099-B Epoxy resin containing carbazole structure, and preparation method and application thereof 中国石油化工股份有限公司 2024-06-28 CN disclosed
CN-115505100-B Epoxy resin based on spirosilafluorene as framework, and preparation method and application thereof 中国石油化工股份有限公司 2024-06-28 CN disclosed
US-11795188-B2 Transition metal compound and method for producing olefin polymer IDEMITSU KOSAN CO., LTD. (JP) 2023-10-24 US disclosed
US-20230235202-A1 PLASTICIZER FOR RESINS IDEMITSU KOSAN CO.,LTD. (JP) 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11795188-B2 Transition metal compound and method for producing olefin polymer H1-0, C9, C5 ALDH1A1 3156/4885KDM4E 3654/4885GAA 3941/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.